# SECUADO
> **NDA212268** · New Drug Application · Sponsor: HISAMITSU · Approved 2019-10-11
## Drug
- **FDA Application Number:** NDA212268
- **Application type:** New Drug Application
- **Brand name:** SECUADO
- **Generic name:** ASENAPINE
- **Active ingredients:** ASENAPINE
- **Dosage form:** SYSTEM
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** HISAMITSU
- **Manufacturer:** Noven Therapeutics, LLC
- **First approval:** 2019-10-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212268)
---
*MORVS · CC0 1.0*